作者:Paul Barraclough、James W. Black、David Cambridge、David Firmin、V. Paul Gerskowitch、R. C. Glen、Heather Giles、Janet M. Gillam、Robert A. D. Hull、Ramachandran Iyer、Peter Randall、Gita P. Shah、Steven Smith、Mark V. Whiting
DOI:10.1002/ardp.19923250407
日期:——
Aryl substituted 1H‐imidazo[1, 2‐a]imidazole 8, imidazo[2,1‐b]thiazole 9, 1,4‐dihydroimidazo[4,5‐d]imidazole 11, and 1(2),4‐dihydroimidazo[4,5‐c]pyrazoles 12–17 have been prepared. An X‐ray crystallographic study confirmed the structure of 8 and showed this analogue to exist as the 1H‐tautomer. These heterocycles were evaluated as inotropic agents and analogues 12, 15, and 17 found to display inotropic
芳基取代的 1H-咪唑并[1, 2-a]咪唑 8、咪唑并[2,1-b]噻唑 9、1,4-二氢咪唑并[4,5-d]咪唑 11 和 1(2),4-二氢咪唑已制备 [4,5-c] 吡唑 12-17。X 射线晶体学研究证实了 8 的结构,并表明该类似物以 1H 互变异构体的形式存在。这些杂环被评估为肌力剂和类似物 12、15 和 17,发现它们显示的肌力特性在体外较弱,但在体内比舒咪唑更有效。讨论了构效关系。